No tears left to cry, is it dry eye disease?

Written by: Mr Allaaeldin Abumattar
Edited by: Lauren Dempsey

Dry eye disease is a condition caused by the inability of the eye to lubricate itself. This can be caused by inadequate tear production or tears that dry up quicker than usual. In our latest online article, esteemed consultant ophthalmic surgeon Mr Allaaeldin Abumattar shares his expertise on the subject. The Swindon-based surgeon discusses the causes, symptoms, treatment, and management of the condition. 


What causes dry eyes?

In recent years, there has been an increase in awareness of the condition and rising diagnostic rates. Fifteen to 33% of the UK population aged 65 years or over have dry eye disease. The prevalence of dry eye disease increases with age by about 8%-10% per decade, but dry eye disease is not uncommon in younger people. Some factors that make dry eye disease more likely include refractive surgery, contact lens wear (50-75% of contact lens wearers report eye irritation associated with dry eye), and digital device use which is currently very common in the younger population. 

Other causes of dry eyes are chronic blepharitis and meibomian gland disease (MGD). Diabetes, thyroid disorders, Sjogren’s syndrome, lupus, scleroderma, rheumatoid arthritis, and other systemic diseases are associated with dry eyes. Certain medications can decrease tear production and cause dry eyes such as antihistamines, beta-blockers, oral contraceptives, and glaucoma drops. Hormonal changes in pregnancy or menopause in females and androgen deficiency in males might trigger dry eye. Environmental conditions such as exposure to low humidity, drying winds, high room temperature, air velocity, and pollution exacerbate dry eye symptoms. 

Finally, women are more likely to suffer from dry eye disease than men, postmenopausal oestrogen therapy, radiation therapy, hematopoietic stem cell transplantation (HSCT), dietary deficiencies, and hepatitis can all cause dry eye. 


What are the symptoms of dry eyes? 

Certainly, a drier eye is a frequent complaint of people with dry eye, but dry eye patients also experience a foreign-body sensation, grittiness, burning, and redness. Itching and a small amount of discharge, although normally associated with allergic conjunctivitis, can affect patients with dry eye disease. 

If the basal rate of tears, tears that continuously moisten the eye, is inadequate, the reflexive tears engage. The reflexive tears occur due to pain or external stimulus, which could potentially lead to an overproduction of tears and subsequent watery eye, secondary to dry eye.


How can I reduce dry eye symptoms?

Tips for people suffering from dry eye disease include: 

  • Reduce screen time
  • If looking at a screen for an extended period of time, make an effort to reset your eyes at regular intervals by blinking more frequently than usual. 
  • Use eye drops for dry eye disease
  • Be aware that certain medications can decrease tear production and the concurrent use of dry eye medication will be necessary. 
  • If wearing make-up, ensure that it is removed completely

A balanced diet supplies the eyes with the vitamins and nutrients they need, but supplements can also help keep your eyes nourished. Omega-3 is an anti-inflammatory and necessary for oil production in the meibomian gland. Vitamin D can improve the effectiveness of artificial tears on the eyes helping to moisten them. Vitamin A helps protect the surface of the eye and a deficiency can increase dry eyes. Zinc also plays a significant role in keeping the eyes healthy as it is necessary for the correct absorption of Vitamin A in the body. Lutein and zeaxanthin are antioxidants that help keep cells healthy and functioning correctly. Staying hydrated is also crucial.

What should I avoid with dry eye disease? 

  • Avoid dry environments, distancing yourself from indoor heating units, fans, and air conditioners. Additionally, avoid driving with the window open. 
  • When possible, reduce screen time
  • Don’t overwear contacts, keep them clean, and never forget to take them out at night. 
  • Smoking cigarettes can aggravate the condition, as the smoke and fumes can dry out your eyes in addition to the toxic chemicals that can damage them.
  • Avoid eyedrops designed for red eyes.
  • If you are using dry eye drops that aren’t working for you, don’t hesitate to change them. Some drops might work well for some people and not as well as for others.


What treatments are available for dry eye disease?

The first step in the treatment of dry eye is educating the patient about the condition, management, and prognosis. Modifying the patient’s local environment, identifying any potentially etiologic systemic/topical medications, practicing proper lid hygiene, applying warm compresses, and applying ocular lubricants are all important in the treatment of dry eye disease.


The second step is the use of non-preserved ocular lubricants to minimize preservative-induced toxicity, tear conservation therapy such as punctual occlusion or moisture chamber spectacles/goggles, overnight treatments like ointment or moisture chamber, physical heating, and expression of the meibomian glands.


Earlier diagnosis and treatment of dry eye could significantly improve the quality of life, but unfortunately, there is no one-size-fits-all treatment. Other than eye lubrication, several different options are available for the relief of dry eye symptoms, but no one option is universally effective. For cases of mild dry eye disease, they can be treated with drops up to four times a day, but in more severe cases, the use of drops can increase up to 10-12 times a day. Thick artificial teardrops, or gels used in more severe cases and ointments may be used at night, rarely during the day. Topical steroids can help temporarily calm inflammation. Topical immunomodulators, such as cyclosporine addresses the role of the immune response in the cycle of dry eye. Punctual plugs are successful treatments for some types of dry eye disease also.

If you would like to book a consultation with Mr Allaaeldin Abumattar, you can do so directly from his Top Doctors profile. 

By Mr Allaaeldin Abumattar

Mr Allaaeldin Abumattar is an exceptionally well-regarded and highly experienced consultant ophthalmic surgeon who specialises in cataract surgeryage-related macular degeneration (AMD)diabetic retinopathy, retinal vein occlusions as well as glaucoma.  Mr Abumattar moved to Swindon in January 2017, where he is currently the age-related macular degeneration (AMD) clinical lead, and is the ophthalmology clinical tutor for university medical school students. 

Mr Abumattar possesses an extensive amount of experience in relation to the management of eyelid conditions and disorders, such as lower lid and upper lid malposition surgerytherapeutic botulinum toxin injection as an effective treatment option for facial dystonia and thyroid eye disease. Impressively, Mr Abumattar developed and provided a structured approach to both the data collection and decision-making in relation to the overall management of thyroid eye disease, which, in 2014, was presented to The British Oculoplastic Surgery Society. 

Following his graduation in 1994; obtaining a degree in medicine from the established Al Fetah University; Mr Abumattar undertook his training in ophthalmology at both the El Nasir Ophthalmic Hospital and the St John of Jerusalem Eye Hospital. He then moved to the UK in 2001, immediately undertaking training posts at the Ayrshire and Arran Acute Hospitals Trust. Following this, he began at a post at the Stoke Mandeville Hospital, where he was awarded with the SAS (Staff grade and Associate Specialists) Clinical Discretionary Award in 2006. 

Throughout his career, Mr Abumattar has developed quite the interest in the incorporation of standard and premium implant for cataract surgery and also for effectively correcting astigmatism. He has taught and trained many in the area of ophthalmology to-date, and has engaged himself in clinical trials. He also won the Best Presentation Prize in the SAS Regional Academic Study Day, 2013, for his tips on delivering virtually painless ocular injections in the management of age-related macular degeneration study on "Pain Scores Following Intravitreal Injections." In addition, Mr Abumattar most notably held an honorary fellowship post at Moorfields Eye Hospital in 2013. 

Moreover, Mr Abumattar achieved responsibilities as Trust Appraiser, the Director of the Buckinghamshire Postgraduate Ophthalmology Teaching Programme, Member of the Joint Consultation and Negotiating Committee (JCNC) for doctors and dentists in Oxfordshire Deanery, representative in the Royal College of Ophthalmologists SAS group, and SAS representative in Royal College revalidation sub-committee. He was also awarded a Local Clinical Excellence Award in 2021 in recognition for his service to the NHS. 

View Profile

Overall assessment of their patients

This website uses our own and third-party Cookies to compile information with the aim of improving our services, to show you advertising related to your preferences as well analysing your browsing habits. You can change your settings HERE.